- Home
- ABLV vs CRIS Comparison
ABLV vs CRIS Comparison
Compare ABLV & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABLV
- CRIS
- Stock Information
- Founded
- ABLV 2015
- CRIS 2000
- Country
- ABLV China
- CRIS United States
- Employees
- ABLV N/A
- CRIS N/A
- Industry
- ABLV
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ABLV
- CRIS Health Care
- Exchange
- ABLV Nasdaq
- CRIS Nasdaq
- Market Cap
- ABLV 38.1M
- CRIS 32.8M
- IPO Year
- ABLV N/A
- CRIS 2000
- Fundamental
- Price
- ABLV $1.11
- CRIS $3.19
- Analyst Decision
- ABLV
- CRIS Strong Buy
- Analyst Count
- ABLV 0
- CRIS 3
- Target Price
- ABLV N/A
- CRIS $23.00
- AVG Volume (30 Days)
- ABLV 7.3K
- CRIS 245.7K
- Earning Date
- ABLV 01-01-0001
- CRIS 02-06-2025
- Dividend Yield
- ABLV N/A
- CRIS N/A
- EPS Growth
- ABLV N/A
- CRIS N/A
- EPS
- ABLV N/A
- CRIS N/A
- Revenue
- ABLV $130,087,189.00
- CRIS $10,259,000.00
- Revenue This Year
- ABLV N/A
- CRIS N/A
- Revenue Next Year
- ABLV N/A
- CRIS N/A
- P/E Ratio
- ABLV N/A
- CRIS N/A
- Revenue Growth
- ABLV N/A
- CRIS 0.44
- 52 Week Low
- ABLV $0.55
- CRIS $2.86
- 52 Week High
- ABLV $3.94
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- ABLV 67.79
- CRIS 42.29
- Support Level
- ABLV $0.62
- CRIS $2.86
- Resistance Level
- ABLV $1.16
- CRIS $3.60
- Average True Range (ATR)
- ABLV 0.11
- CRIS 0.38
- MACD
- ABLV 0.04
- CRIS 0.02
- Stochastic Oscillator
- ABLV 89.83
- CRIS 20.12
About ABLV Able View Global Inc.
Able View Global Inc operates as a brand management partner of international beauty and personal care brands in China. It provides full-service solutions covering marketing plan, branding, digital and social marketing, omni-channel sales, customer service, overseas logistics, warehouse, and fulfillment. The firm generates revenue from product sales by distributing and selling cross-border products from various brand owners to Chinese consumers.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.